Skip to main content
Erschienen in: European Journal of Epidemiology 8/2014

01.08.2014 | CARDIOVASCULAR DISEASE

Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study

verfasst von: Gry Wisthus Eveborn, Henrik Schirmer, Per Lunde, Geir Heggelund, John-Bjarne Hansen, Knut Rasmussen

Erschienen in: European Journal of Epidemiology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

To disclose risk factors of incident aortic stenosis (AS) and progression of established AS. A prospective cohort study. The Tromsø Study, a population based health survey. Over a 14 years span we performed three repeated echocardiographic examinations (1994, 2001 and 2008) of a random sample of initially 3,243 participants. Data from the only hospital serving this population were included in the follow up. Throughout the study 132 participants were diagnosed with incident AS, defined as mean aortic valve gradient ≥15 mmHg. Cox proportional hazards regression disclosed age (HR 1.11, 95 %CI 1.08–1.14), systolic blood pressure (BP) (HR 1.01, 95 % CI 1.00–1.02), active smoking (HR 1.71, 95 % CI 1.09–2.67), and waist circumference (HR 1.02, 95 % CI 1.00–1.03) as independent predictors of incident AS. Analysis of risk factors for progression of AS disclosed a higher mean aortic gradient at first measurement (p = 0.015), weight (p = 0.015), a low haemoglobin (Hgb) (p = 0.030) and high density lipoprotein (HDL) (p = 0.032) as significant independent predictors. Age, systolic BP, smoking and waist circumference were independent predictors of incident AS, whereas cholesterol was not. Mean aortic gradient at first measurement, weight, an elevated HDL and low Hgb increase the progression rate of the disease. Our data indicate that calcific aortic valve disease is a distinct pathophysiological process, with age, smoking and “wear and tear” of the valve being major contributors to the disease development.
Literatur
1.
Zurück zum Zitat Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111(24):3316–26.PubMedCrossRef Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111(24):3316–26.PubMedCrossRef
2.
Zurück zum Zitat Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.PubMedCrossRef Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.PubMedCrossRef
3.
Zurück zum Zitat Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. cardiovascular health study. J Am Coll Cardiol. 1997;29(3):630–4.PubMedCrossRef Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. cardiovascular health study. J Am Coll Cardiol. 1997;29(3):630–4.PubMedCrossRef
4.
Zurück zum Zitat Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21(5):1220–5.PubMedCrossRef Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21(5):1220–5.PubMedCrossRef
7.
8.
10.
Zurück zum Zitat Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation. 2006;113(17):2113–9.PubMedCrossRef Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation. 2006;113(17):2113–9.PubMedCrossRef
11.
Zurück zum Zitat Stritzke J, Linsel-Nitschke P, Markus MR, et al. Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey. Eur Heart J. 2009;30(16):2044–53. doi:10.1093/eurheartj/ehp287.PubMedCrossRef Stritzke J, Linsel-Nitschke P, Markus MR, et al. Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey. Eur Heart J. 2009;30(16):2044–53. doi:10.​1093/​eurheartj/​ehp287.PubMedCrossRef
12.
Zurück zum Zitat Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Prac. 2003;94(2):c40–5. doi:10.1159/000071280.CrossRef Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Prac. 2003;94(2):c40–5. doi:10.​1159/​000071280.CrossRef
13.
Zurück zum Zitat Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999;84(9):1044–8.PubMedCrossRef Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999;84(9):1044–8.PubMedCrossRef
14.
Zurück zum Zitat Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000;101(21):2497–502.PubMedCrossRef Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000;101(21):2497–502.PubMedCrossRef
16.
Zurück zum Zitat Nassimiha D, Aronow WS, Ahn C, Goldman ME. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol. 2001;87(11):1313–4.PubMedCrossRef Nassimiha D, Aronow WS, Ahn C, Goldman ME. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol. 2001;87(11):1313–4.PubMedCrossRef
17.
Zurück zum Zitat Yamamoto K, Yamamoto H, Yoshida K, et al. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Hypertens Res. 2010;33(3):269–74. doi:10.1038/hr.2009.225.PubMedCrossRef Yamamoto K, Yamamoto H, Yoshida K, et al. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Hypertens Res. 2010;33(3):269–74. doi:10.​1038/​hr.​2009.​225.PubMedCrossRef
18.
Zurück zum Zitat Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.PubMedCrossRef Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.PubMedCrossRef
24.
Zurück zum Zitat Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844–53.PubMedCrossRef Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844–53.PubMedCrossRef
26.
Zurück zum Zitat Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262–70.PubMedCrossRef Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262–70.PubMedCrossRef
28.
Zurück zum Zitat Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85(6):635–8.PubMedCentralPubMedCrossRef Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85(6):635–8.PubMedCentralPubMedCrossRef
Metadaten
Titel
Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study
verfasst von
Gry Wisthus Eveborn
Henrik Schirmer
Per Lunde
Geir Heggelund
John-Bjarne Hansen
Knut Rasmussen
Publikationsdatum
01.08.2014
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 8/2014
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-014-9936-x

Weitere Artikel der Ausgabe 8/2014

European Journal of Epidemiology 8/2014 Zur Ausgabe